DB15689InvestigationalSmall molecule
Azoximer bromide is under investigation in clinical trial NCT04381377 (Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19).
- Also known as
- Poly((1-(carboxymethyl)piperazin-1-ium-1,4-diyl bromide)ethylene-co-((piperazin-1,4-diyl 1-oxide)ethylene)
Resolves to
Compound
What you can answer from here — as of February 21, 2021
Which companies are running trials of Azoximer bromide, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account